EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3328-3329. doi: 10.1007/s00259-022-05864-z.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Consensus
  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • Humans
  • Lutetium / therapeutic use
  • Male
  • Positron Emission Tomography Computed Tomography* / methods
  • Prostate-Specific Antigen
  • Prostatic Neoplasms, Castration-Resistant*

Substances

  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • Lutetium
  • Prostate-Specific Antigen